Applied Therapeutics logo
Applied Therapeutics APLT
$ 9.82 6.05%

Quarterly report 2024-Q2
added 08-07-2024

report update icon

Applied Therapeutics Income Statement 2011-2024 | APLT

Annual Income Statement Applied Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

541 M 35.2 M 78.8 M 470 M 682 M - - - - - - - -

Shares

84.2 M 37.8 M 25.6 M 22.4 M 12.8 M - - - - - - - -

Historical Prices

6.42 0.93 3.08 20.9 52.5 - - - - - - - -

Net Income

-120 M -82.5 M -106 M -94 M -45.5 M -16.5 M -4.28 M - - - - - -

Revenue

9.99 M - - - - - - - - - - - -

Cost of Revenue

- - - - - - - - - - - - -

Gross Profit

- - - - - - - - - - - - -

Operating Income

-64.5 M -83 M -106 M -94.5 M -45.6 M -13.5 M - - - - - - -

Interest Expense

-27 K -177 K -521 K -54 K -24 K -1.14 M - - - - - - -

EBITDA

-64.5 M -83 M -106 M -94.1 M -45.6 M -13.3 M -4.28 M - - - - - -

Operating Expenses

74.5 M 83 M 106 M 94.5 M 45.6 M - - - - - - - -

General and Administrative Expenses

20.6 M 27.3 M 43 M 32.7 M 13.2 M 2.05 M 582 K - - - - - -

All numbers in USD currency

Quarterly Income Statement Applied Therapeutics

2024-Q2 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

144 M 84.9 M 90.7 M 79 M 56.4 M 48.1 M 48 M 26.9 M 26.2 M 26.2 M 26.2 M 26.1 M 24.1 M 22.5 M 22.4 M 22.1 M 20.8 M 18.5 M 17.1 M 13.9 M 5.51 M 5.51 M 5.5 M 5.46 M 5.46 M - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Net Income

2.9 M - -42.4 M -29.6 M -10.1 M - -19.1 M -25.9 M -23.1 M - -28.4 M -25.8 M -24.2 M - -29.8 M -28.1 M -12.4 M - -10.7 M -8.44 M -45.5 M - -4.28 M -3.18 M -2.34 M - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Revenue

144 K - - - 10.7 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cost of Revenue

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Gross Profit

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Income

-20.4 M - -15.5 M -17.2 M -10.9 M - -19.4 M -21.5 M -23.1 M - -28.4 M -25.9 M -24.2 M - -30 M -28.3 M -12.5 M - -10.7 M -8.44 M -8.73 M - -3.32 M -2.34 M -1.87 M - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Interest Expense

-34 K - 10 K -5 K 31 K - -8 K -90 K -96 K - -64 K -122 K -56 K - -10 K 38 K -24 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

EBITDA

-20.4 M - -15.5 M -17.2 M -10.9 M - -19.4 M -21.5 M -23.1 M - -28.4 M -25.9 M -24.2 M - -30 M -28.3 M -12.5 M - -10.7 M -8.44 M -8.73 M - -3.32 M -2.34 M -1.87 M - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Expenses

20.6 M - 15.5 M 17.2 M 21.5 M - 19.4 M 21.5 M 23.1 M - 28.4 M 25.9 M 24.2 M - 30 M 28.3 M 12.5 M - 10.7 M 8.44 M 8.73 M - 3.32 M 2.34 M 1.87 M - - - - - - - - - - - - - - - - - - - - - - - - - - - -

General and Administrative Expenses

10.6 M - 4.71 M 5.29 M 5.58 M - 6.24 M 6.12 M 8.07 M - 10.8 M 11.1 M 9.75 M - 10 M 7.52 M 5.2 M - 3.29 M 4.18 M 1.86 M - 598 K 400 K 420 K - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency